Efficacy and safety of prophylactic simultaneous intravitreal moxifloxacin injection with standard intravitreal anti-VEGF injection procedure in cases of cystoid macular edema and macular neovascularization.

BMC Ophthalmol · 2025 · PMC12096712 · PMID 40405143

Europe PMC DOI

hedged sentence

0.5020

closest p · 10.0× alpha

0.5020

boldest claim

The sentences

did not reach statistical significanceP = 0.502not close (p > 0.1)

0.2%) did not reach statistical significance ( P = 0.502), the absence of cases in the moxifloxacin group—despite higher baseline retinal disruption—supports its safety and warrants larger trials to confirm efficacy.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.